Try our Advanced Search for more refined results

CESTRA et al v. CEPHALON, INC. et al

  1. June 03, 2015

    Cephalon Must Face Most Of FCA Off-Label Marketing Suit

    A Pennsylvania federal judge allowed most of a False Claims Act case accusing Cephalon Inc. of a kickback scheme involving off-label drug marketing to continue Wednesday, saying the whistleblower had pled sufficient facts to proceed to discovery.

  2. March 31, 2015

    Cephalon Wants FCA Off-Label Marketing Claims Axed

    Pharmaceutical company Cephalon Inc. urged a Pennsylvania federal judge on Tuesday to nix a pair of whistleblower suits accusing it of spurring false reimbursement claims to the government through a scheme to promote three of its drugs off-label.

  3. November 06, 2014

    Cephalon Wants FCA Off-Label Suits Heard Separately

    Cephalon Inc. told a Pennsylvania federal court Wednesday that two remaining False Claims Act cases against it for off-label promotion should not be consolidated, arguing that since the relators' Fentora claims have been dismissed, they no longer share common matters of fact.

  4. October 10, 2014

    Off-Label Claims In Cephalon FCA Suits Trimmed By Judge

    A Pennsylvania federal judge on Thursday trimmed allegations from two False Claims Act complaints accusing Cephalon Inc. of promoting painkiller Fentora and other drugs for off-label uses, finding that whistleblowers parroted earlier allegations.